Chemotherapy for uterine cancer

Chemotherapy uses anticancer, or cytotoxic, drugs to destroy cancer cells. It is sometimes used to treat uterine cancer. Your healthcare team will consider your personal needs to plan the drugs, doses and schedules of chemotherapy. You may also receive other treatments.

Chemotherapy is sometimes combined with radiation therapy to treat some types of uterine cancer. This is called chemoradiation. The 2 treatments are given during the same time period.

Sometimes a few cycles of chemotherapy are given, followed by radiation, and then chemotherapy is given again. This is called sandwich therapy. It may be used for some types of endometrial carcinoma such as papillary serous carcinoma and carcinosarcoma.

Chemotherapy is given for different reasons. You may have chemotherapy or chemoradiation to:

  • destroy cancer cells in the body

  • destroy cancer cells left behind after surgery and reduce the risk of the cancer recurring (called adjuvant chemotherapy)

  • relieve pain or control the symptoms of advanced uterine cancer (called palliative chemotherapy)

Chemotherapy is usually a systemic therapy. This means that the drugs travel through the bloodstream to reach and destroy cancer cells all over the body, including those that may have broken away from the primary tumour in the uterus.

Chemotherapy drugs used for uterine cancer

The types and combinations of chemotherapy drugs used vary depending on the type of tumour being treated. Usually 2 or more drugs are given in combination to treat uterine cancer.

Endometrial carcinoma

The most common chemotherapy drugs used to treat endometrial carcinoma are:

  • doxorubicin (Adriamycin)

  • liposomal doxorubicin (Myocet)

  • cisplatin (Platinol AQ)

  • carboplatin (Paraplatin, Paraplatin AQ)

  • ifosfamide (Ifex)

  • paclitaxel (Taxol)

  • docetaxel (Taxotere)

The most common drug combinations used to treat endometrial carcinoma are:

  • cisplatin and doxorubicin

  • paclitaxel and doxorubicin

  • carboplatin and paclitaxel

  • cisplatin, paclitaxel and doxorubicin


Carcinosarcoma may be treated with ifosfamide alone or combined with carboplatin, cisplatin or paclitaxel.

Uterine sarcoma

The most common chemotherapy drugs used to treat uterine sarcoma are:

  • doxorubicin

  • liposomal doxorubicin

  • ifosfamide

  • cisplatin

  • paclitaxel

  • docetaxel

  • gemcitabine (Gemzar)

  • dacarbazine (DTIC)

  • temozolomide (Temodal)

  • vinorelbine (Navelbine)

  • trabectedin (Yondelis)

A common chemotherapy combination used to treat uterine sarcoma is docetaxel and gemcitabine.

Side effects

Side effects can happen with any type of treatment for uterine cancer, but everyone's experience is different. Some people have many side effects. Other people have few or none at all.

Chemotherapy may cause side effects because it can damage healthy cells as it kills cancer cells. Side effects can develop any time during, immediately after or a few days or weeks after chemotherapy. Sometimes late side effects develop months or years after chemotherapy. Most side effects go away on their own or can be treated, but some side effects may last a long time or become permanent.

Side effects of chemotherapy will depend mainly on the type of drug, the dose, how it's given and your overall health. Some common side effects of chemotherapy drugs used for uterine cancer are:

Tell your healthcare team if you have these side effects or others you think might be from chemotherapy. The sooner you tell them of any problems, the sooner they can suggest ways to help you deal with them.

Information about specific drugs

Details on specific drugs change quite regularly. Find out more about sources of drug information and where to get details on specific drugs.

Questions to ask about chemotherapy

Find out more about chemotherapy and side effects of chemotherapy. To make the decisions that are right for you, ask your healthcare team questions about chemotherapy.

Expert review and references

  • Alektiar KM, Abu-Rustum NR, Fleming GF . Cancer of the uterine body. DeVita VT Jr, Lawrence TS, Rosenberg SA. Cancer: Principles and Practice of Oncology. 10th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2015: 73:1048-1064.
  • Almadrones Cassidy, L . Endometrial cancer. Yarbro CH, Wujcki D, Holmes GB (eds.). Cancer Nursing: Principles and Practice. 7th ed. Sudbury, MA: Jones and Bartlett; 2011: 53: 1281-1294.
  • American Cancer Society. Uterine Sarcoma. 2014:
  • American Cancer Society. Endometrial (Uterine) Cancer. 2015:
  • American Society of Clinical Oncology. Uterine Cancer. 2014:
  • Cancer Care Ontario. Drug Formulary. Toronto, ON: Cancer Care Ontario;
  • Levine DA, Dizon DS, Yashar CM, Barakat RR, Berchuch A, Markman M, Randall ME. Handbook for Principles and Practice of Gynecologic Oncology. 2nd ed. Philadelphia, PA: Wolters Kluwer; 2015.
  • National Cancer Institute. Endometrial Cancer Treatment for Health Professionals (PDQ®). 2015:
  • National Cancer Institute. Uterine SarcomaTreatment for Health Professionals (PDQ®). 2015:

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on, nor do we endorse any service, product, treatment or therapy.

1-888-939-3333 | | © 2024 Canadian Cancer Society